Upcoming Event: Antibody Engineering Asia
11/12/2007
Event: Antibody Engineering Asia
Organizer: IBC Asia
Venue: Meritus Mandarin, Singapore
Dates: February 25 - 28, 2008
Hear the latest and most cutting-edge scientific research in antibody engineering by speakers from all over the world, from academia institutions and successful commercial corporations.
This is a not-to-be missed event if you would like to advance your knowledge and get updates on what your peers are doing in antibody engineering and therapeutics research, benchmark best practices against your own, find out how to make money from this ever-growing business by learning from others?success and failure case examples, including ways to raise funds, form partnerships and overcome legal barriers and IP issues.
Immunogenicity has been the most talked about topic ever since the TeGenero incident. Attend the post-conference symposium to learn how to prevent and reduce immunogenicity to develop your antibody into the next multibillion blockbuster drug!
Key Speakers:
* Dr John Chiplin, Chief Executive Officer, Peptech, Australia
* Professor Roy Jefferis, Division of Immunity and Infection,
University of Birmingham, UK
* Dr William R. Strohl, Executive Director, Department of Biologics
Research, Merck Research Laboratories, USA
* Professor Dexian Zheng, Chinese Academy of Medical Sciences &
Peking Union Medical College, Tsinghua University, China
* Professor Florian R黭er, Department of Biotechnology, Institute of
Applied Microbiology, BOKU, Austria
* Dr Hiroshi Ueda, Integrated Biosciences, University of Tokyo, Japan
* Dr Patrick Liu, Associate Director, Development Sciences,
Genentech, Inc.
* Professor Paola Castagnoli, Scientific Director, Singapore
Immunology Network (SIgN), Singapore
* Professor Thomas Valerius, Division of Nephrology, University of
Schleswig-Holstein, Germany
* Dr Zhenping Zhu, Vice President, ImClone Systems Inc., USA
* Dr Neil Brewis, VP Research, Biopharm CEDD, Domantis, UK
* Dr Hitoshi Yoshida, Head of Research, Human Antibody Group of
Discovery Research Laboratories, Kirin Pharma, Japan
To find out more, pls contact: